Hector Keun
Imperial College London
H-index: 63
Europe-United Kingdom
Top articles of Hector Keun
Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study.
Clinical Cancer Research
2024/4/5
Abstract B096: Targeting RNA splicing factor RBM39 improves therapy responses in ovarian high-grade serous carcinoma
Cancer Research
2024/3/4
Corrigendum to" In-utero and childhood chemical exposome in six European mother-child cohorts"[Environ. Int. 121 (Part 1)(2018) 751-763]
Environment International
2024/3
Hyperacetylated histone H4 is a source of carbon contributing to lipid synthesis
The EMBO Journal
2024/2/21
Blurred lines: Crossing the boundaries between the chemical exposome and the metabolome
2024/2/1
A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer
Clinical Cancer Research
2023/4/14
Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: A panel study
Environment International
2023/3/1
Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts
BMC medicine
2023/2/28
The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality
2023
Chemical Tools for Profiling the Intracellular ADP-ribosylated Proteome
bioRxiv
2023
Heme oxygenase-1 expressing omental macrophages as a therapeutic target in ovarian high grade serous carcinoma
bioRxiv
2023
RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer
Molecular Cell
2023/12/7
Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma
Cell Reports
2023/10/31
P-179 Altered lipid metabolism in IMiD/CELMoD resistant multiple myeloma confers novel and targetable vulnerabilities
Clinical Lymphoma Myeloma and Leukemia
2023/9/1
Associations of four biological age markers with child development: A multi-omic analysis in the European HELIX cohort
Elife
2023/6/6
miR-22-enriched breast cancer cells display repressed glycolytic metabolism, increased glycogen synthesis, and reduced survival in low glucose conditions
Molecular Biology Reports
2023/6
Cobalt-Doped g-C3N4 Nanosheets for One-Pot Synthesis of Imines under Mild Conditions
CLINICAL CANCER RESEARCH
2023/4/15
Urinary metabolic biomarkers of diet quality in European children are associated with metabolic health
Elife
2022/1/25
Multi-omics signatures of the human early life exposome
Nature communications
2022/11/21